Moderna has received a six-month, $1.97B contract modification from the U.S. Army to manufacture 100M more doses of the company's messenger RNA vaccine against the novel coronavirus.
Army Contracting Command ordered additional filled drug production doses of the mRNA-1273 vaccine from the biotechnology firm by using the first option and acetate-related efforts under a previously awarded contract, the Department of Defense said Monday.
Cambridge, Massachusetts-based Moderna developed the vaccine with the National Institute of Allergy and Infectious Diseases and received an emergency use authorization from the Food and Drug Administration on Dec. 18.
The company received the full amount of the award and is expected to finish work under the modification by June 30.
DOD and the Department of Health and Human Services signed a $1.5B deal with Moderna in August to procure 100M initial vaccine doses of the vaccine.
Anderon finalized a $1 billion CHIPS Act award with Commerce for its Albany quantum wafer foundry, matched by $1 billion…
CACI's Apollo program is intended to help USCENTCOM make faster decisions and coordinate more effectively across commands and partners.
Ret. Air Force Lt. Gen. David Deptula joins the board alongside Stacey Dixon, who previously led IARPA.
IVIX's Don Fort has said AI-enabled OSINT platforms could help agencies convert public data into actionable intelligence.
Chris Carson brings more than 40 years of financial and government contracting experience to AMERICAN SYSTEMS.
TSA has unveiled plans for a follow-on test and evaluation support BPA solicitation, which is expected in March 2027.
OSINT is vital for U.S. IC leadership to better understand Chinese leadership’s motivations due to inability to access top leadership.
Rocket Lab has completed a $1.94 billion at-the-market offering, fully financing its pending acquisition of Iridium.
Watson joined a tribally owned federal contracting business with more than $1 billion in annual revenue and over 5,000 employees.
Lentech has appointed Ryan Rohr, former chief strategy officer at Thomson Reuters Special Services, as chief growth officer.
Brooke Pierce spent seven years at Leidos, most recently serving as vice president of defense enterprise and cyber operations division.
TechnoMile VP Timothy Brett, a GovCon Expert, examines why critical capture intelligence fails to reach federal proposal teams.
You’ve already read all related articles.
VIDEO 
